The importance of taking a history of over-the-counter medication use: A brief review and case illustration of "pRN" antihistamine dependence in a hospitalized adolescent

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 6, 2010, Pages 521-524

  Gracious, Barbara ^a   Abe, Naomi ^b   Sundberg, Jane ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; DULOXETINE; HYDROXYZINE; NALTREXONE; NON PRESCRIPTION DRUG; SERTRALINE;

ADOLESCENT; ANAMNESIS; ANXIETY DISORDER; BIPOLAR DISORDER; CASE REPORT; CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SEEKING BEHAVIOR; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HOSPITAL PATIENT; HUMAN; SUBSTANCE ABUSE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; MEDICAL HISTORY TAKING; NALTREXONE; NARCOTIC ANTAGONISTS; NONPRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 78650633937     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0031     Document Type: Conference Paper

References (21)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
2. Banks ML, Anderson ML, Murnane KS, Meyer RC, Howell LL: Behavioral and neurochemical effects of cocaine and diphenhy-dramine combinations in rhesus monkeys. Psychopharmacologia 205:467-474, 2009.
3. Bolden C, Cusack B, Richelson E: Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260:576-580, 1992.
4. Centers for Disease Control and Prevention (CDC): Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR 59:705-710, 2010.
5. Cox D, Ahmed Z, McBride AJ: Dephenhydramine dependence. Addiction 96:516-517, 2001. de Nesnera AP: Diphenhydramine dependence: A need for awareness. J Clin Psychiatry 57:136-137, 1996.
6. Drug Abuse Warning Network: Emergency department visits. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration. 2006. Available at https:// dawninfo.samhsa.gov/. Accessed June 23 2010.
7. Epidemiologic Trends in Drug Abuse Advance Report, Community Epidemiology Work Group; June 2006. US Dept of Health and Human Services National Institute on Drug Abuse. NIH publication No. 06-5878A. Available at http://www/drugabuse. gov/PDF/CEWG/ Adv-Report606.pdf. Page 45. Last accessed August 11, 2010.
8. Feldman MD, Behar M: A case of massive diphenhydramine abuse and withdrawal from use of the drug. JAMA 255:3119-3120, 1986.
9. Ford JA: Misuse of over-the-counter cough or cold medications among adolescents: Prevalence and correlates in a national sample. Adolesc Health 44:505-507, 2009.
10. Kaplan SL, Busner J: The use of prn and stat medication in three child psychiatric inpatient settings. Psychopharmacol Bull 33:161-164, 1997.
11. Lessenger JE, Feinberg SD: Abuse of prescription and over-the-counter medications. J Am Board Fam Med 21:45-54, 2008.
12. Lessenger JE, Lessenger LH, Lessenger EW: An Outcome Analysis of Drug Court in Tulare County, California. Visalia, CA: Tulare County Superior Court, 2000.
13. Levine DA: 'Pharming': The abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr 19:270-274, 2007.
14. National Survey on Drug Use and Health: Characteristics of Primary Prescription and OTC Treatment Admissions: 2002. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, 2004.
15. Partnership for a Drug-Free America: The Partnership Attitude Tracking Study. New York: Partnership for a Drug-Free America. 2005. Available at www.drugfree.org/Files/Full-Teen-Report. Accessed June 23 2010.
16. Radovanovic D, Meier PJ, Guirguis M, Lorent JP, Kupferschmidt H: Dose-dependent toxicity of diphenhydramine overdose. Hum Exp Toxicol 19:489-495, 2000.
17. Roberts K, Gruer L, Gilooly T: Misuse of diphenhydramine soft gel capsules (Sleepia): A cautionary tale from Glasgow. Addiction 94:1575-1578, 1999.
18. Smith SG, Gupta KK, Smith SH: Effects of naltrexone on self-injury, stereotypy, and social behavior of adults with developmental disabilities. J Dev Phys Disabil 7:137-146, 1995.
19. Symons FJ, Thompson A, Rodriguez MC: Self-injurious behavior and the efficacy of naltrexone treatment: A quantitative synthesis. Ment Retard Dev Disabil Res Rev 10:193-200, 2004.
20. Tanda G, Kopajtic TA, Katz JL: Cocaine-like neurochemical effects of antihistamininic medications. J Neurochem 106:147-157, 2008.
21. Thomas A, Nallur DG, Jones N, Deslandes PN: Diphenhydra-mine abuse and detoxification: A brief review and case report. J Psychopharmacol 23:101-105, 2009.